The Cyprus Institute of Neurology and Genetics at ESGCT 2026

Oct 27–30, 2026 Hamburg, Germany ~2.5k attendees Website

The Cyprus Institute of Neurology and Genetics brings 2 presentations to ESGCT 2026 in Hamburg. Its work centres on inherited blood and iron disorders. Topics include base editing TMPRSS6 without cutting the DNA to inactivate the gene in iron-loading disease and a lentiviral platform for alpha-zero thalassemia.

OrganizationESGCT 2026 Attendance
Poster
Wed Oct 28
1:30pm–3:30pm
DSB-free TMPRSS6 base editing for targeted gene inactivation in iron-loading disorders
Gene Editing
Poster
Thu Oct 29
2:00pm–4:00pm
A lentiviral gene therapy platform for α⁰-thalassemia: vector design and preclinical evaluation
Lentiviral vectors / Integrative vectors

Explore the full ESGCT 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Hamburg. Leave your work email and we’ll be in touch.

Privacy

Download the full ESGCT 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from The Cyprus Institute of Neurology and Genetics

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by the European Society of Gene & Cell Therapy. Submit a correction